Please use this identifier to cite or link to this item:
http://hdl.handle.net/11434/947
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Grummet, Jeremy | - |
dc.contributor.author | Moon, Daniel | - |
dc.contributor.other | Pepdjonovic, Lana | - |
dc.date | 2016-10 | - |
dc.date.accessioned | 2016-12-06T03:06:48Z | - |
dc.date.available | 2016-12-06T03:06:48Z | - |
dc.date.issued | 2016 | - |
dc.identifier.citation | Vol.70, 29 Oct. 2016 | en_US |
dc.identifier.issn | 0302-2838 | en_US |
dc.identifier.uri | http://hdl.handle.net/11434/947 | - |
dc.description.abstract | In a recent review, Borghesi et al concluded that sepsis is the most troublesome complication following transrectal prostate biopsy and that its incidence continues to increase due to the ongoing rise of fluoroquinolone resistance. We believe the time is nigh to abandon the transrectal approach. In performing transrectal biopsy, we forsake basic surgical principles of sterility for the convenience of this approach, using antibiotics as a substitute for hygiene. Quinolones are recommended as standard prophylaxis, but are losing their effect. The US Center for Disease Control states that “use of antibiotics is the single most important factor leading to resistance around the world”. The World Health Organization implores us to reduce unnecessary antibiotic usage for fear of creating a postantibiotic era. Proposed preventative solutions to prostate biopsy sepsis involving multidrug or broader spectrum prophylaxis are therefore in direct contravention of these warnings and are irresponsible. Continues. | en_US |
dc.publisher | Elsevier | en_US |
dc.subject | Complications | en_US |
dc.subject | Hospitalisation | en_US |
dc.subject | Infection | en_US |
dc.subject | MRI-Guided Biopsy | en_US |
dc.subject | Mortality | en_US |
dc.subject | Sepsis | en_US |
dc.subject | Transrectal Prostate Biopsy | en_US |
dc.subject | Fluoroquinolone Resistance | en_US |
dc.subject | Sterility | en_US |
dc.subject | Prophylaxis | en_US |
dc.subject | UroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australia | en_US |
dc.subject | Australian Prostate Cancer Research Centre, Epworth HealthCare, Victoria, Australia. | en_US |
dc.title | Re: Marco Borghesi, Hashim Ahmed, Robert Nam, et al. Complications after systematic, random, and image-guided prostate biopsy. | en_US |
dc.type | Letter | en_US |
dc.identifier.doi | doi.org/10.1016/j.eururo.2016.08.004 | en_US |
dc.identifier.journaltitle | European Urology | en_US |
dc.description.pubmeduri | https://www.ncbi.nlm.nih.gov/pubmed/27543165 | en_US |
dc.description.affiliates | Department of Urology, Alfred Hospital, Melbourne, Victoria, Australia | en_US |
dc.description.affiliates | Division of Cancer Surgery, University of Melbourne, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia | en_US |
dc.type.contenttype | Text | en_US |
Appears in Collections: | Cancer Services Epworth Prostate Centre UroRenal, Vascular |
Files in This Item:
There are no files associated with this item.
Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.